Roth Capital Begins Coverage on Electromed (NYSE:ELMD)

Roth Capital started coverage on shares of Electromed (NYSE:ELMD - Free Report) in a research note released on Tuesday morning, MarketBeat reports. The firm issued a buy rating and a $29.00 price target on the stock.

A number of other analysts have also recently commented on the stock. Wall Street Zen cut shares of Electromed from a "strong-buy" rating to a "buy" rating in a research report on Thursday, May 8th. B. Riley upgraded shares of Electromed to a "strong-buy" rating in a report on Thursday, May 15th.

Electromed Price Performance

Shares of Electromed stock traded up $0.37 during trading on Tuesday, hitting $19.06. The company's stock had a trading volume of 77,928 shares, compared to its average volume of 82,040. Electromed has a 52 week low of $13.74 and a 52 week high of $35.56. The stock has a market cap of $159.84 million, a price-to-earnings ratio of 25.41 and a beta of 0.41. The stock has a 50-day moving average price of $20.38 and a two-hundred day moving average price of $24.74.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of ELMD. Goldman Sachs Group Inc. boosted its holdings in Electromed by 9.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 32,281 shares of the company's stock worth $770,000 after buying an additional 2,672 shares during the period. Acadian Asset Management LLC boosted its holdings in Electromed by 25.2% in the 1st quarter. Acadian Asset Management LLC now owns 267,975 shares of the company's stock worth $6,388,000 after buying an additional 53,872 shares during the period. Jane Street Group LLC boosted its holdings in Electromed by 136.3% in the 1st quarter. Jane Street Group LLC now owns 56,263 shares of the company's stock valued at $1,342,000 after purchasing an additional 32,456 shares during the period. Dynamic Technology Lab Private Ltd bought a new position in Electromed in the 1st quarter valued at $350,000. Finally, NewEdge Advisors LLC boosted its holdings in Electromed by 20.1% in the 1st quarter. NewEdge Advisors LLC now owns 17,952 shares of the company's stock valued at $428,000 after purchasing an additional 3,001 shares during the period. 40.82% of the stock is owned by institutional investors.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.